MIOGAN PWS 20MG/VIAL DIN 00784826
Health Canada record
| Active ingredient(s) | ACETYLCHOLINE CHLORIDE 20 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intraocular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01EB09 ACETYLCHOLINE |
| Original market date | 31-Dec-1990 |
| Current status date | 04-Aug-2011 |
| Source | Health Canada DPD |
Establishment licence of the holder
Allergan Sales, LLC — licence , not currently licensed, last inspection rating C (2025-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ACETYLCHOLINE CHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02133326 | MIOCHOL-E | BAUSCH & LOMB INC | Powder For Solution | ACETYLCHOLINE CHLORIDE 20 MG | Marketed |
| 00889334 | MIOCHOL E ACETYLCHOLINE CHLORIDE OPH SOLN | IOLAB PHARMACEUTICALS | Powder For Solution | ACETYLCHOLINE CHLORIDE 10 MG | Cancelled Post Market |
International API supply for ACETYLCHOLINE CHLORIDE
0 active FDA Drug Master Files.
Request a quote for MIOGAN PWS 20MG/VIAL